2024    2023    2022    2021    2020    2019    2018    2017    2016   

2023

Articles

31 - 

Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis

Nessrine Bellamri, Marie Lelong, Audrey Joannes, Erwan Le Tallec, Stéphane Jouneau et al.

International Immunopharmacology, 2023, 116, pp.109723.

DOI : https://doi.org/10.1016/j.intimp.2023.109723

Pubmed : 36696855

 

32 - 

Comparing physical activity prescription with verbal advice for general practice patients with cardiovascular risk factors: results from the PEPPER randomised controlled trial

William Bellanger, Matthieu Peurois, L Connan, Nastassia Navasiolava, David Missud et al.

BMC Public Health, 2023, 23 (1),

DOI : https://doi.org/10.1186/s12889-023-16302-6

Pubmed : 37475036

 

33 - 

Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV

Sihem Benaboud, Caroline Solas, Stéphane Bouchet, Matthieu Grégoire, Florian Lemaitre et al.

Journal of Antimicrobial Chemotherapy, 2023, 78 (3), pp.853-854.

DOI : https://doi.org/10.1093/jac/dkad009

Pubmed : 36683308

 

34 - 

Factitious disorder imposed on self: A retrospective study of 2232 cases from health insurance databases

Antoine Berar, Frederic Balusson, Jean-Sébastien Allain

General Hospital Psychiatry, 2023, 85, pp.114-119.

DOI : https://doi.org/10.1016/j.genhosppsych.2023.10.007

Pubmed : 37862960

 

35 - 

Amniotic band syndrome and limb body wall complex in Europe 1980–2019

Jorieke Bergman, Ingeborg Barišić, Marie-Claude Addor, Paula Braz, Clara Cavero-Carbonell et al.

American Journal of Medical Genetics Part A, 2023, 191 (4), pp.995-1006.

DOI : https://doi.org/10.1002/ajmg.a.63107

Pubmed : 36584346

 

36 - 

Medicamentos útiles e inútiles: ¿cómo definirlos? Médicaments utiles et inutiles: comment les définir ?

Jf Bergmann, F. Naudet

Medicamentos útiles e inútiles: ¿cómo definirlos?. Tratado de Medicina, 2023, Emc-Tratado de Medicina, 27 (3), pp.1-6.

DOI : https://doi.org/10.1016/s1636-5410(23)47965-2

 

37 - 

Impact of breast cancer care pathways and related symptoms on the return-to-work process

Mélanie Bertin, A L Rolland, Bertrand Porro, Yves Roquelaure, Sofiane Kab et al.

European Journal of Public Health, 2023, 33 (Supplement_2), pp.ckad160.985.

DOI : https://doi.org/10.1093/eurpub/ckad160.985

 

38 - 

Prospective associations of psychosocial work factors with sickness absence spells and duration: Results from the French national working conditions survey

Sandrine Bertrais, Elodie Pineau, Isabelle Niedhammer

American Journal of Industrial Medicine, 2023,

DOI : https://doi.org/10.1002/ajim.23526

Pubmed : 37563743

 

39 - 

Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022

Kevin Bihan, Lorène Lipszyc, Florian Lemaitre, Anne Dautriche, S Fedrizzi et al.

Therapies, 2023,

DOI : https://doi.org/10.1016/j.therap.2023.03.001

Pubmed : 37012153

 

40 - 

A tridimensional atlas of the developing human head

Raphael Blain, Gérard Couly, Eimad Shotar, Joséphine Blévinal, Maryne Toupin et al.

Cell, 2023, Cell,

DOI : https://doi.org/10.1016/j.cell.2023.11.013

Pubmed : 38070509